RA CAPITAL MANAGEMENT, L.P.
Q3 2020 13F-HR Holdings
Net value change ($000)
+335,402
(6.5%)
New positions
18
Sold out positions
5
Turnover %
19.3%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2020
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| ASND | 185,069 | 25.5% |
| NKTX | 168,490 | NEW |
| MCRB | 134,473 | NEW |
| iTeos Therapeutics, Inc. | 108,974 | NEW |
| PCVX | 87,402 | 50.4% |
| VXRT | 71,893 | NEW |
| PMVP | 60,714 | NEW |
| 89bio, Inc. | 58,528 | 92.9% |
| DYN | 56,634 | NEW |
| INOZYME PHARMA INC | 52,676 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| NVAX | -266,780 | -67.3% |
| Satsuma Pharmaceuticals, Inc. | -116,438 | -86.5% |
| MOMENTA PHARMACEUTICALS INC | -84,221 | -100.0% |
| ADVM | -65,966 | -40.5% |
| ALEC | -62,748 | -62.2% |
| ADAPY | -40,245 | -30.8% |
| ARVN | -36,471 | -29.6% |
| KALA | -32,732 | -28.6% |
| LEGN | -31,287 | -29.6% |
| BDTX | -30,897 | -28.3% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|